FYI
This is today
The U.S. Food and Drug Administration (FDA) has scheduled its late-cycle review meeting for Illuccix® for 16 June 2021, prior to which the FDA intends to communicate to Telix the proposed product labelling for Illuccix®, which may include the indications for use statement.
late-cycle review meeting for Illuccix® and FDA
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.24 |
Change
0.440(2.97%) |
Mkt cap ! $5.036B | |||
| Open | High | Low | Value | Volume |
| $14.71 | $15.24 | $14.61 | $17.69M | 1.179M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2333 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.25 | 10000 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$15.21 |
Change
0.440 ( 2.60 %) |
||||
| Open | High | Low | Volume | ||
| $14.73 | $15.24 | $14.62 | 327752 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| TLX (ASX) Chart |